KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Jazz Pharmaceuticals (JAZZ) over the last 16 years, with Q3 2025 value amounting to $31.9 million.

  • Jazz Pharmaceuticals' Change in Inventory rose 24362.48% to $31.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $112.4 million, marking a year-over-year increase of 29753.19%. This contributed to the annual value of $45.5 million for FY2024, which is 23935.92% up from last year.
  • Latest data reveals that Jazz Pharmaceuticals reported Change in Inventory of $31.9 million as of Q3 2025, which was up 24362.48% from $26.2 million recorded in Q2 2025.
  • Jazz Pharmaceuticals' 5-year Change in Inventory high stood at $35.6 million for Q1 2025, and its period low was -$816000.0 during Q4 2022.
  • In the last 5 years, Jazz Pharmaceuticals' Change in Inventory had a median value of $9.3 million in 2024 and averaged $13.2 million.
  • As far as peak fluctuations go, Jazz Pharmaceuticals' Change in Inventory tumbled by 10545.09% in 2022, and later soared by 122941.6% in 2024.
  • Jazz Pharmaceuticals' Change in Inventory (Quarter) stood at $15.0 million in 2021, then crashed by 105.45% to -$816000.0 in 2022, then surged by 272.06% to $1.4 million in 2023, then surged by 1229.42% to $18.7 million in 2024, then soared by 70.96% to $31.9 million in 2025.
  • Its Change in Inventory was $31.9 million in Q3 2025, compared to $26.2 million in Q2 2025 and $35.6 million in Q1 2025.